Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 18Neoplasm Metastasis 8Esophageal Neoplasms 8Carcinoma, Hepatocellular 7Melanoma 6Lung Neoplasms 6Neoplasms 5Breast Neoplasms 5Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Head and Neck Neoplasms 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Small Cell Lung Carcinoma 2Recurrence 2Rectal Neoplasms 2Pathologic Complete Response 2Nasopharyngeal Carcinoma 2Gastrointestinal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma 2Breast Neoplasms, Male 2Turcot syndrome 1Triple Negative Breast Neoplasms 1Solid Tumor Cancer 1Small Cell Lung Cancer Extensive Stage 1Sarcoma 1Radiation Injuries 1Prostatic Neoplasms 1Pleural Mesothelial Neoplasm 1

Interventions

Diathermy 6Radiotherapy 2Surgical Procedures, Operative 1Solutions 1Saline Solution 1Patient Reported Outcome Measures 1Paclitaxel 1Immunotherapy 1Ifosfamide 1Hyperthermia, Induced 1Hydrogen Peroxide 1Doxorubicin 1Dacarbazine 1Cryotherapy 1Carboplatin 1AC protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hyperthermia × Immunotherapy × 1 year × Clear all
NCT07118566 2025-08-12

Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases

China Medical University, China

Phase 2 Not yet recruiting
40 enrolled
Gastrointestinal

Hyperthermia, Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡